Ticker Details
Guardant Health, Inc.
IPO Date:	October 1, 2018
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$21.76B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.96 | 3.13%
Avg Daily Range (30 D):	$4.44 | 3.26%
Avg Daily Range (90 D):	$3.47 | 3.26%

Institutional Daily Volume
Avg Daily Volume:	1.36M
Avg Daily Volume (30 D):	2.32M
Avg Daily Volume (90 D):	1.96M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	57
Avg Trade Size (Sh.) (90 D):	58

Institutional Trades
Total Institutional Trades:	9,277
Avg Institutional Trade:	$3.83M
Avg Institutional Trade (30 D):	$16.61M
Avg Institutional Trade (90 D):	$9.85M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$9.21M
Avg Closing Trade (30 D):	$91.4M
Avg Closing Trade (90 D):	$45.17M
Avg Closing Volume:	147.71K

News

Jun 19, 2026 @ 9:39 AM Ovarian Cancer Diagnostics Market Size to Reach US... Source: Sns Insider

Jun 8, 2026 @ 9:25 AM Why Grail Could Be the Sleeper Stock Everyone's Ab... Source: Keith Speights

Jun 5, 2026 @ 8:42 AM AI-Powered Imaging Systems and Deep Learning Softw... Source: Researchandmarkets.Com

May 20, 2026 @ 4:07 PM Guardant Health Secures FDA Approval For Expanded ... Source: Vandana Singh

May 13, 2026 @ 5:00 PM Global Colorectal Cancer Diagnostics and Therapeut... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.4	$-.85
Diluted EPS	$-3.4	$-.85
Revenue	$1.08B	$301.67M
Gross Profit	$701.01M	$196.75M
Net Income / Loss	$-433.19M	$-112.08M
Operating Income / Loss	$-447.56M	$-121.35M
Cost of Revenue	$379.2M	$104.92M
Net Cash Flow	$297.1M	$612.02M
PE Ratio